Showing results (681-690 of 1,984) with videos related to
Sort By:
Pageof 199
International Journal of Immunopharmacology|April 1, 1993
CD4-binding compounds: an assay to detect new classes of immunopharmacological agentsG Chandler, C Elcock, P Depledge, et al.International Journal of Immunopharmacology|April 1, 1993
The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cellsJ Semmler, H Wachtel, S EndresInternational Journal of Immunopharmacology|January 1, 1996
Induction of ileum muscarinic cholinoceptor signal transduction pathways by rat interferon-gammaL Sterin-Borda, E Borda, M E Sales, et al.International Journal of Immunopharmacology|January 1, 1996
Further evidence on the interaction of muramyl dipeptide with the serotonergic systemJ Slánský, O Kadlec, J Sevcík, et al.International Journal of Immunopharmacology|January 1, 1996
Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferationA F Haczku, A B Kay, C J CorriganInternational Journal of Immunopharmacology|April 1, 1995
Leflunomide prevents the development of experimentally induced myasthenia gravisB Vidic-Dankovic, D Kosec, M Damjanovic, et al.International Journal of Immunopharmacology|April 1, 1995
Immunoregulatory potential of exogenous Schistosoma mansoni soluble egg antigen in a model of experimental schistosomiasis--I. Regulation of granuloma formation in vivoS S Botros, H I Hassanein, S I Hassan, et al.International Journal of Immunopharmacology|April 1, 1995
The thymus atrophy-inducing organotin compound DBTC inhibits the binding of thymocytes to thymic epithelial cellsR H Pieters, R Albers, R Bleumink, et al.International Journal of Immunopharmacology|January 1, 1989
Selective immunosuppression following exposure to a novel anthraquinone, 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD)R V House, L D Lauer, L M Thurmond, et al.International Journal of Immunopharmacology|January 1, 1989
Methyl-acetylenicputrescine (MAP), an inhibitor of polyamine biosynthesis, reduces the frequency and cytolytic activity of alloantigen-induced LyT 2.2 positive lymphocytes in vivoT L Bowlin, B J McKown, K K SchroederPageof 199